Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma

Neoadjuvant Treatment Response in Negative Nodes Is an Important Prognosticator After Esophagectomy

(2015) Dylan R. Nieman et al.   ANNALS OF THORACIC SURGERY

Role of Repeat18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma

(2015) Moshim Kukar et al.   JAMA Surgery

Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction

(2014) Andrew R. Davies et al.   JOURNAL OF CLINICAL ONCOLOGY

The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma

(2013) Ashleigh M. Francis et al.   ANNALS OF SURGERY

Ineffectiveness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Tumor Response After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer

(2013) Guillaume Piessen et al.   ANNALS OF SURGERY

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data

(2013) Ulrich Ronellenfitsch et al.   EUROPEAN JOURNAL OF CANCER

Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer

(2013) James P. Dolan et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

The impact of comorbidity on cancer survival: a review

(2013) Mette Sogaard et al.   Clinical Epidemiology

Minimally Invasive Esophagectomy with Cervical Esophagogastric Anastomosis

(2012) Steven N. Hochwald et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer

(2010) Kenneth L. Meredith et al.   ANNALS OF SURGICAL ONCOLOGY

Outcomes of Patients With Esophageal Cancer Staged With [18F]Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection?

(2010) Arta Monir Monjazeb et al.   JOURNAL OF CLINICAL ONCOLOGY

Technique of Minimally Invasive Ivor Lewis Esophagogastrectomy with Intrathoracic Stapled Side-to-Side Anastomosis

(2010) Kfir Ben-David et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

(2009) James M. Donahue et al.   ANNALS OF THORACIC SURGERY

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis

(2008) E. Bollschweiler et al.   ANNALS OF ONCOLOGY

Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy

(2008) Matthias Schmidt et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING